|
"su fy"的相關文件
顯示項目 1-10 / 17 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2022-01 |
The impact of frailty on the outcomes of hemodialysis vascular access
|
Chen, CH;Hsieh, YL;Chuang, SY;Su, FY;Wang, KT;Luo, CM;Meng, SW;Wu, CC |
| 國家衛生研究院 |
2021-01-15 |
Redox sensor NPGPx restrains ZAP70 activity and modulates T cell homeostasis
|
Su, FY;Huang, SC;Wei, PC;Hsu, PH;Li, JP;Su, LW;Hsieh, YL;Hu, CM;Hsu, JL;Yang, CY;Chung, CY;Shew, JY;Lan, JL;Sytwu, HK;E, YHL;Lee, WH |
| 國家衛生研究院 |
2019-11 |
NPGPx-mediated adaptation to oxidative stress protects motor neurons from degeneration in aging by directly modulating O-GlcNAcase
|
Hsieh, YL;Su, FY;Tsai, LK;Huang, CC;Ko, YL;Su, LW;Chen, KY;Shih, HM;Hu, CM;Lee, WH |
| 國家衛生研究院 |
2019-10 |
Redox sensor NPGPx restrains ZAP70 recruitment to lipid rafts for modulating TCR responses and autoimmunity
|
Su, FY;Huang, SC;Wei, PC;Hsu, PH;Li, JP;Lan, JL;Sytwu, HK;Lee, WH |
| 國立交通大學 |
2019-04-02T06:04:20Z |
Multipurpose virtual-reality-based motion simulator
|
Lin, CT; Chung, IF; Liann, SA; Su, FY |
| 國家衛生研究院 |
2016-10 |
Multifunctional nanoparticles for oral protein drug delivery
|
Chuang, EY;Lin, KJ;Su, FY;Mi, FL;Chen, CT;Juang, JH;Sung, HW |
| 國家衛生研究院 |
2016-02 |
Multifunctional nanoparticles for oral protein drug delivery
|
Chuang, EY;Lin, KJ;Su, FY;Mi, FL;Chen, CT;Juang, JH;Sung, HW |
| 國立交通大學 |
2014-12-08T15:27:00Z |
Multipurpose virtual-reality-based motion simulator
|
Lin, CT; Chung, IF; Liann, SA; Su, FY |
| 國家衛生研究院 |
2014-04 |
Treatment of chemotherapy-induced neutropenia in a rat model by using multiple daily doses of oral administration of G-CSF-containing nanoparticles
|
Su, FY;Chuang, EY;Lin, PY;Chou, YC;Chen, CT;Mi, FL;Wey, SP;Yen, TC;Lin, KJ;Sung, HW |
| 國家衛生研究院 |
2013-10 |
Noninvasive imaging oral absorption of insulin delivered by nanoparticles and its stimulated glucose utilization in controlling postprandial hyperglycemia during OGTT in diabetic rats
|
Chuang, EY;Lin, KJ;Su, FY;Mi, FL;Maiti, B;Chen, CT;Wey, SP;Yen, TC;Juang, JH;Sung, HW |
顯示項目 1-10 / 17 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
|
